Amending the earlier order, the authority on Saturday issued a fresh one allowing the firm to continue the production of these medicines.
In an affidavit filed in the top court, the SLA has given details of the steps taken by it against Patanjali and Divya Pharmacy.
The Kerala High Court has stayed all proceedings in a lower court against Yoga guru Baba Ramdev, his associate Acharya Balakrishna and their company Divya Pharmacy in a "misleading" advertisement case. The court found merit in their claim that cognisance of the offence was taken after the period of limitation.
The notice says the company can restart manufacturing these products only after the authority approves their revised formulation sheets.
The judgment could impact not only Ramdev's widespread ayurveda and herbal products business, but also that of many other pharmaceutical, ayurveda, herbal and cosmetic product manufacturers.
Putrajeevak Beej, the medicine from Baba Ramdev's pharmacy, promises the delivery of a male child.
The Supreme Court on Tuesday reserved its order on the contempt notice issued to yoga guru Ramdev, his aide Balkrishna and Patanjali Ayurved Ltd in the misleading advertisements case.
Patanjali Ayurved, in collaboration with NIMS University, launched Coronil and Shwasari Vati, claiming to cure corona patients.
In 1993, Rochelle Chhabra joined Streax as an R&D employee. Today, she heads their professional division.
'Cracking the exam is 99 per cent hard work and persistence and maybe 1 per cent luck.'
'Frankly, no one is prepared for Begin Again or whatever this is called.'
The controversy over Sant Rampal and his army of followers taking the law into their hands has once again thrown the spotlight on the clout that India's godmen possess.
Patanjali, to a large extent, has penetrated the target group for its products. As a result, increasing the consumer base and revenue by 100 per cent in FY18 will be a stiff challenge.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances